tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Promising Future for Eupraxia Pharmaceuticals: Buy Rating Affirmed on Strong EP-104GI Trial Results
PremiumRatingsPromising Future for Eupraxia Pharmaceuticals: Buy Rating Affirmed on Strong EP-104GI Trial Results
1M ago
Eupraxia Pharmaceuticals initiated with a Buy at H.C. Wainwright
Premium
The Fly
Eupraxia Pharmaceuticals initiated with a Buy at H.C. Wainwright
1M ago
Eupraxia Pharmaceuticals initiated with a Speculative Buy at Canaccord
Premium
The Fly
Eupraxia Pharmaceuticals initiated with a Speculative Buy at Canaccord
1M ago
Eupraxia Pharmaceuticals Reports Positive Nine-Month Outcomes in EoE Trial
PremiumCompany AnnouncementsEupraxia Pharmaceuticals Reports Positive Nine-Month Outcomes in EoE Trial
3M ago
Eupraxia Pharmaceuticals announces treatment outcomes for EP-104GI
Premium
The Fly
Eupraxia Pharmaceuticals announces treatment outcomes for EP-104GI
3M ago
Eupraxia Pharmaceuticals to Showcase Clinical Advances at April and May Conferences
Premium
Company Announcements
Eupraxia Pharmaceuticals to Showcase Clinical Advances at April and May Conferences
3M ago
Eupraxia Pharmaceuticals’ EP-104GI shows efficacy in esophagitis trial
PremiumThe FlyEupraxia Pharmaceuticals’ EP-104GI shows efficacy in esophagitis trial
5M ago
Craig-Hallum starts Eupraxia at Buy, sees ‘significant upside’ potential
Premium
The Fly
Craig-Hallum starts Eupraxia at Buy, sees ‘significant upside’ potential
5M ago
Eupraxia Pharmaceuticals  initiated with a Buy at Craig-Hallum
Premium
The Fly
Eupraxia Pharmaceuticals initiated with a Buy at Craig-Hallum
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100